|
Class 2 Device Recall Configura Advance Chair |
|
Date Initiated by Firm |
June 21, 2021 |
Create Date |
September 13, 2021 |
Recall Status1 |
Open3, Classified |
Recall Number |
Z-2453-2021 |
Recall Event ID |
88441 |
Product Classification |
Chair, with casters - Product Code INM
|
Product |
Configura Advance Chair, Model Number: CHAIR-0-SC1-030; Advance Chair, 100mm Castors, Std Backrest, Manual; Serial Numbers: 10001-SC1-20 to 10483-SC1-20; 10001-SC1-21 to 10224-SC1-21; 10231-SC1-21 to 10456-SC1-21; 10481-SC1-21 to 10570-SC1-21.
Model Number: CHAIR-0-SC2-030; Advance Chair, 100mm (4in) Castors, Std Backrest, Electric; Serial Numbers: 10001-SC2-20 to 10135-SC2-20; 10001-SC2-21 to 10240-SC2-21.
Model Number: CHAIR-0-SC3-050; Advance Chair, 125/150mm (5in/6in) Castors, Standard Backrest, Manual; Serial Numbers: 10116-SC3-20 to 10145-SC3-20; 10236-SC3-20 to 10295-SC3-20; 10001-SC3-21 to 10090-SC3-21; 10271-SC3-21 to 10360-SC3-21; 10001-SC3-20 to 10115-SC3-20; 10146-SC3-20 to 10235-SC3-20.
Model Number: CHAIR-0-SC4-050; Advance Chair, 125/150mm (5in/6in) Castors, Standard Backrest, Electric; Serial Numbers: 10001-SC4-20 to 10030-SC4-20. |
Code Information |
Serial Numbers (Domestically distributed) 10001-SC3-20 to 10115-SC3-20
10146-SC3-20 to 10235-SC3-20 |
Recalling Firm/ Manufacturer |
Accora Inc 9210 Corporate Blvd Ste 120 Rockville MD 20850-6226
|
Manufacturer Reason for Recall |
The firm has identified a potential for the backrest to become detached from the chair.
|
FDA Determined Cause 2 |
Device Design |
Action |
On June 21, 2021, the firm sent affected customers Urgent Field Safety Notices via email. The notice identified the affected products and informed customers of the product issue. The corrective action will be to fit a modification kit to eliminate this fault condition and ensure the backrest cannot detach from the chair. All new production chairs will have this kit fitted as standard.
Customers should make sure that all caregivers and users of the affected Configura Advance Chair devices are made aware of this Field Safety Notice. Furthermore, they should contact Accora to arrange a Field Safety Corrective Action kit to be installed on each product. This will be fitted free of charge.
If you have questions or require assistance, please contact Accora:
Accora Limited, Charter House, Barrington Road, Orwell, Cambridge SG8 5QP
T: +44 (0)1223 206100 E: info@accora.care |
Quantity in Commerce |
122 (US); 270 (OUS) |
Distribution |
Worldwide distribution - US Nationwide in the states of AL, FL, IL, MN, MS, NH, NJ, NY, NC, OH, PA, SC and the countries of Ireland, UK, and Australia. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|